Cristina Papayannidis

Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study

Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier et al. · Journal of Clinical Oncology · 2017 · 446 citations · Full text

Medicine, Hematology, Oncology +16

<i>IKZF1</i> (Ikaros) Deletions in <i>BCR-ABL1</i> –Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report

Giovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi et al. · Journal of Clinical Oncology · 2009 · 322 citations

Medicine, Hematology, Oncology +17

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

Sara Trabanelli, Mathieu F. Chevalier, Amaia Martínez-Usatorre et al. · Nature Communications · 2017 · 226 citations · Full text

Life Sciences, Immunology, Oncology +16

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1–positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP)

Ilaria Iacobucci, Clelia Tiziana Storlazzi, Daniela Cilloni et al. · Blood · 2009 · 220 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors

Simona Soverini, Alessandra Gnani, Sabrina Colarossi et al. · Blood · 2009 · 174 citations · Full text

Medicine, Genetics, Oncology +16